MFS
PTLA

MSI Financial Services’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

MSI Financial Services’s Portfolio PTLA Stock Details PTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$3K Buy
120
+20
+20% +$391 ﹤0.01% 3410
2016
Q3 		$2K Buy
+100
New +$2.35K ﹤0.01% 3581
2016
Q1 		– Sell
-1,000
Closed -$51K – 4161
2015
Q4 		$51K Buy
+1,000
New +$48.5K ﹤0.01% 1712

Other funds holding PTLA

Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

MSI Financial Services's PTLA Position: Q4 2016 in Review

MSI Financial Services increased its Portola Pharmaceuticals, Inc. (PTLA) stake by 20% in Q4 2016, buying an estimated $391 and bringing the position to 120 shares worth $3K. The position accounts for ﹤0.01% of the portfolio, ranked #3410.

MSI Financial Services first reported a position in PTLA in Q4 2015 and has held it in 3 quarters since. The position peaked at $51K in Q4 2015. 150 funds tracked by Wall St. Rank hold PTLA as of Q4 2016.

  • MSI Financial Services held 120 shares of Portola Pharmaceuticals, Inc. worth $3K as of Q4 2016.
  • MSI Financial Services bought 20 Portola Pharmaceuticals, Inc. shares in Q4 2016, an estimated $391.
  • Portola Pharmaceuticals, Inc. made up ﹤0.01% of MSI Financial Services's portfolio in Q4 2016, its #3410 holding.
  • MSI Financial Services first reported a position in Portola Pharmaceuticals, Inc. in Q4 2015 and has held it in 3 quarters since.
  • MSI Financial Services's Portola Pharmaceuticals, Inc. position peaked at $51K in Q4 2015.
  • 150 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q4 2016.

Based on MSI Financial Services's 13F filing for Q4 2016, filed 13 Jan 2017.